Medical Verdicts and Law Weekly

Amarin Corp. plc - European phase III trial for Miraxion in Huntington disease commences

American Oriental Bioengineering, Inc. - Chinese pharmaceutical firm reports options to trade on Chicago Board Options Exchange

American Society of Hematology - Research identifies new biomarker for pulmonary hypertension in sickle cell patients

American Society of Hematology - Scientists may be able to use novel antibody to target specific cells leading to AML

Amgen - Biotech company to acquire Abgenix for $22.50 per share

Aphios Corp. - Vitamin D analog for prostate cancer licensed from Boston University Medical School

Applied NeuroSolutions, Inc. - Alzheimer disease therapy developer renews consulting agreement with Peter Davies

Applied Precision, LLC - Distribution agreement signed with Cellomics for cell analysis system

Assaf Harofeh Medical Center, Zerifin - Tubo-ovarian abscess unresponsive to therapy may be sign of fallopian tube cancer

AstraZeneca - Data show survival benefit of Arimidex over tamoxifin in early breast cancer

AstraZeneca - Studies evaluate impact of switching on survival in adjuvant treatment of early breast cancer

Australian National University, Acton - Researchers publish new studies and findings in the area of oncology

Axcan Pharma, Inc. - Patient randomization target exceeded for completion of North American Itax phase III trial

B. Braun Medical, Inc. - Infusion-pump distribution agreement extended

BSD Medical Corp. - University Medical School in Munich, Germany expands capacity for cancer treatment

Basal Cell Cancer - Basal cell carcinomas presented with unusual histologic patterns

Baskent University, Adana - Effectiveness of transbronchial needle aspiration in diagnosing endobronchial lung cancers assessed

Baxter Healthcare Corp. - U.S. FDA Class I classification given to Meridian Hemodialysis Instrument recall

Best Practices, LLC - Market research study shows profitable pharma partnerships are mutually beneficial

Bioniche Life Sciences, Inc. - Canadian biopharmaceutical firm completes private financing

Biostem, Inc. - Investrend Research initiates coverage of company acquiring Cryobanks International, Inc.

Biothera - Phase I trial for Imprime PGGTM cancer therapy initiated

Boehringer Ingelheim - Non-nucleoside inhibitors characterized for hepatitis C virus NS5B polymerase

Boston University - Cardiac endothelial cells express multiple variants of neuregulin-1

Breast Cancer - Case of nodular fascitis of the breast presented

Breast Cancer - Sentinel lymph node biopsy reduces incidence of lymphedema and erysipelas

Brown University, Providence - Detoxified endotoxin vaccine protects against lethal polymicrobial sepsis

Brown University, Providence - Study reviews published strategies to enhance treatment fidelity of health behavior interventions

Cancer Therapy - Drug-development company starts clinical trial with PHP in first-line extension

Cardiac Science Corp. - Defibrillation device developer completes first Pyramis implementation

Cardiff University - Off-loading devices used in diabetic ulcer to reduce plantar pressure were evaluated

Cardiome Pharma Corp. - Phase IIa study for oral RSD1235 initiated in patients with atrial fibrillation